VPC-70063
CAS No. 13571-44-3
VPC-70063( Thiourea, N-[3,5-bis(trifluoromethyl)phenyl]-N'-(phenylmethyl)- )
Catalog No. M28492 CAS No. 13571-44-3
VPC-70063 is an inhibitor of c-Myc-MAX. VPC-70063 exhibits Myc-Max transcriptional activity inhibition of 106% with an IC50 of 8.9 μM and Myc-Max/UBE2C downstream pathway inhibition of 94%. VPC-70063 can be used for studies about anticancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 132 | In Stock |
|
| 5MG | 103 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 282 | In Stock |
|
| 50MG | 398 | In Stock |
|
| 100MG | 579 | In Stock |
|
| 200MG | 817 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVPC-70063
-
NoteResearch use only, not for human use.
-
Brief DescriptionVPC-70063 is an inhibitor of c-Myc-MAX. VPC-70063 exhibits Myc-Max transcriptional activity inhibition of 106% with an IC50 of 8.9 μM and Myc-Max/UBE2C downstream pathway inhibition of 94%. VPC-70063 can be used for studies about anticancer.
-
DescriptionVPC-70063 is an inhibitor of c-Myc-MAX. VPC-70063 exhibits Myc-Max transcriptional activity inhibition of 106% with an IC50 of 8.9 μM and Myc-Max/UBE2C downstream pathway inhibition of 94%. VPC-70063 can be used for studies about anticancer.(In Vitro):VPC-70063 (6.25, 12.5, and 25 μM) causes apoptosis of LNCaP cells as indicated by cleavage of PARP. VPC-70063 (0-500 μM) disrupts the interaction of Myc-Max with DNA in a dose-dependent manner.
-
In VitroVPC-70063 (25 μM; 96 h) shows Myc-Max transcriptional activity inhibition of 106% and Myc-Max/UBE2C downstream pathway inhibition of 94%.VPC-70063 (6.25-25 μM, 48 h) causes apoptosis of LNCaP cells as indicated by cleavage of PARP.VPC-70063 (0-500 μM; 0-600 s) disrupts the interaction of Myc-Max with DNA in a dose dependent manner.Western Blot Analysis Cell Line:LNCaP cells Concentration:6.25 μM, 12.5 μM and 25 μM Incubation Time:48 h Result:Induced PARP cleavage.
-
In Vivo——
-
SynonymsThiourea, N-[3,5-bis(trifluoromethyl)phenyl]-N'-(phenylmethyl)-
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorP2X3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number13571-44-3
-
Formula Weight378.33
-
Molecular FormulaC16H12F6N2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC(F)(F)C1=CC(=CC(=C1)C(F)(F)F)NC(=S)NCC=2C=CC=CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
DMU-212
DMU-212, a methylated form of Resveratrol, shows antimitotic, antiproliferative, and antioxidant activities. DMU-212 induces mitotic arrest through the activation of ERK1/2 protein and the promotion of apoptosis.
-
Necrostatin-7
Necrostatin-7 (Necrostatin 7) is an inhibitor of necrotic apoptosis with cardioprotective effects, inhibits RANK-NFATc1 signaling, and attenuates macrophage differentiation into osteoblasts.
-
SACLAC
SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
Cart
sales@molnova.com